Form 4: Tandem Diabetes Care EVP & COO Awarded Significant Equity Compensation

Jean-Claude Kyrillos, Executive Vice President and Chief Operating Officer of Tandem Diabetes Care Inc., has been granted performance stock units and restricted stock units totaling over 24,000 shares under the company's long-term incentive plan.

Summary

• Jean-Claude Kyrillos, EVP & Chief Operating Officer of Tandem Diabetes Care Inc. (TNDM), was awarded equity compensation on May 30, 2025.
• The awards include 12,114 Performance Stock Units (PSUs) and 12,115 Restricted Stock Units (RSUs).
• Each PSU represents a contingent right to receive one share of common stock, with the number of shares issued ranging from 0% to 200% (up to 24,228 shares) based on pre-defined performance metrics as of December 31, 2027, and continuous service.
• Each RSU represents a contingent right to receive one share of common stock or cash in lieu thereof, at the Issuer's discretion.
• RSUs will vest 33% on May 15, 2026, with the remaining shares vesting in eight equal quarterly installments thereafter.
• Both awards were granted pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended.
• Following these reported transactions, Mr. Kyrillos beneficially owns 10,709 shares of Common Stock directly, in addition to the newly awarded derivative securities.

Sentiment

Score: 7

Explanation: The document reports routine equity awards to a key executive, which is a positive for aligning management incentives with shareholder interests, but not a significant market-moving event on its own.

Positives

• The equity awards align the interests of a key executive, Jean-Claude Kyrillos, with those of the shareholders, as a significant portion of his compensation is tied to company performance and stock value.
• The performance-based nature of the PSUs incentivizes the achievement of specific company metrics, potentially driving future growth and profitability.

Risks

• The Performance Stock Units (PSUs) are subject to the achievement of pre-defined performance metrics by December 31, 2027; if minimum metrics are not met, no PSUs will vest, posing a risk to the executive's potential compensation.
• The vesting of both PSUs and RSUs is contingent on the awardee's continuing service through the respective vesting and measurement dates, creating a retention risk for the company if the executive departs.

Future Outlook

The future outlook for the executive's equity compensation is tied to the company's performance through December 31, 2027, for PSUs, and a multi-year vesting schedule for RSUs extending beyond May 2026.

Management Comments

• The awards were made pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, indicating a structured approach to executive compensation.

Industry Context

This filing reflects a standard practice in the medical device and biotechnology industries, where executive compensation often includes significant equity components to incentivize long-term performance and align management interests with shareholder value creation.

Corporate Governance

Stakeholder Impact

• Shareholders: The awards align the interests of a key executive with shareholders, potentially leading to better long-term performance, but also represent potential future dilution from share issuance upon vesting.
• Employees: The awards are part of the executive compensation structure, which can set a precedent or standard for other employee incentive programs within the company.

Next Steps

• Monitoring of Tandem Diabetes Care's performance against the pre-defined metrics for the Performance Stock Units (PSUs) until December 31, 2027.
• Tracking the vesting schedule of the Restricted Stock Units (RSUs), with the first vesting event on May 15, 2026, followed by quarterly installments.

Key Dates

Keywords

Tandem Diabetes Care, TNDM, Jean-Claude Kyrillos, SEC Form 4, Equity Compensation, Performance Stock Units, Restricted Stock Units, Insider Transaction, Executive Compensation, Long-Term Incentive Plan, Diabetes Management